CrossrefInfokarte
Rebisufligene etisparvovec: The first AAV9-mediated SGSH gene therapy approved for the treatment of mucopolysaccharidosis type IIIA (MPS IIIA)
Drug Discoveries & Therapeutics · 2026-10-31 · 20 (5) · 403-404
DOI: 10.5582/ddt.2026.01082 ↗Abstract
Kein Abstract verfügbar.
EUVIMED